(DEA) Eerly Govt Ppty - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US27616P3010
Stock: Office, Leasing, Acquisition, Management, Development
Total Rating 26
Risk 44
Buy Signal -0.09
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.41% |
| Yield on Cost 5y | 3.34% |
| Yield CAGR 5y | 6.39% |
| Payout Consistency | 95.2% |
| Payout Ratio | 9.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.1% |
| Relative Tail Risk | -5.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.17 |
| Alpha | -16.01 |
| Character TTM | |
|---|---|
| Beta | 0.607 |
| Beta Downside | 0.964 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.24% |
| CAGR/Max DD | -0.20 |
Description: DEA Eerly Govt Ppty January 19, 2026
Easterly Government Properties, Inc. (NYSE: DEA) is a Washington, D.C.–based REIT that acquires, develops, and manages Class A office assets leased almost exclusively to U.S. federal agencies, either directly or through the General Services Administration (GSA). Its business model hinges on long-term, credit-worthy government leases that typically include built-in rent escalations and renewal options.
Key performance indicators (KPIs) that investors watch include:
- Occupancy ≈ 96% (2023 year-end), reflecting the high demand for secure government space.
- Funds from Operations (FFO) growth of ~4% YoY in 2023, driven by rent escalations and modest portfolio expansion.
- Debt-to-Equity ratio of ~1.2×, indicating a leveraged but manageable capital structure given the low-risk tenant base.
Sector drivers that materially affect DEA’s outlook are:
- Federal discretionary spending trends, especially in defense and homeland security, which set the ceiling for agency-level space demand.
- GSA lease-rate adjustments tied to the Consumer Price Index, influencing rent growth across the portfolio.
- Macro-interest-rate environment; lower rates reduce borrowing costs and support REIT valuations, while rate hikes can pressure acquisition financing.
For a data-rich, side-by-side comparison of DEA’s valuation metrics and scenario analysis, consult ValueRay’s dedicated DEA dashboard.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 13.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.02 > 1.0 |
| NWC/Revenue: -403.7% < 20% (prev -64.94%; Δ -338.8% < -1%) |
| CFO/TA 0.07 > 3% & CFO 241.8m > Net Income 13.9m |
| Net Debt (1.17b) to EBITDA (197.0m): 5.92 < 3 |
| Current Ratio: 0.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (44.7m) vs 12m ago 7.43% < -2% |
| Gross Margin: 66.83% > 18% (prev 0.66%; Δ 6617 % > 0.5%) |
| Asset Turnover: 10.10% > 50% (prev 9.60%; Δ 0.50% > 0%) |
| Interest Coverage Ratio: 0.59 > 6 (EBITDA TTM 197.0m / Interest Expense TTM 148.3m) |
Altman Z'' -2.17
| A: -0.39 (Total Current Assets 70.1m - Total Current Liabilities 1.39b) / Total Assets 3.38b |
| B: 0.04 (Retained Earnings 140.3m / Total Assets 3.38b) |
| C: 0.03 (EBIT TTM 88.1m / Avg Total Assets 3.24b) |
| D: 0.07 (Book Value of Equity 136.1m / Total Liabilities 2.00b) |
| Altman-Z'' Score: -2.17 = D |
Beneish M -3.31
| DSRI: 0.59 (Receivables 66.0m/101.0m, Revenue 327.3m/297.8m) |
| GMI: 0.99 (GM 66.83% / 66.02%) |
| AQI: 1.10 (AQ_t 0.18 / AQ_t-1 0.16) |
| SGI: 1.10 (Revenue 327.3m / 297.8m) |
| TATA: -0.07 (NI 13.9m - CFO 241.8m) / TA 3.38b) |
| Beneish M-Score: -3.31 (Cap -4..+1) = AA |
What is the price of DEA shares?
As of February 07, 2026, the stock is trading at USD 24.16 with a total of 357,314 shares traded.
Over the past week, the price has changed by +3.29%, over one month by +11.59%, over three months by +15.10% and over the past year by -4.73%.
Over the past week, the price has changed by +3.29%, over one month by +11.59%, over three months by +15.10% and over the past year by -4.73%.
Is DEA a buy, sell or hold?
Eerly Govt Ppty has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold DEA.
- StrongBuy: 1
- Buy: 0
- Hold: 4
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the DEA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.9 | -1% |
| Analysts Target Price | 23.9 | -1% |
| ValueRay Target Price | 26 | 7.6% |
DEA Fundamental Data Overview February 03, 2026
P/E Trailing = 77.9667
P/E Forward = 64.1026
P/S = 3.6073
P/B = 0.7998
Revenue TTM = 327.3m USD
EBIT TTM = 88.1m USD
EBITDA TTM = 197.0m USD
Long Term Debt = 1.64b USD (from longTermDebt, last quarter)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 1.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.17b USD (from netDebt column, last quarter)
Enterprise Value = 2.37b USD (1.21b + Debt 1.17b - CCE 4.36m)
Interest Coverage Ratio = 0.59 (Ebit TTM 88.1m / Interest Expense TTM 148.3m)
EV/FCF = 9.81x (Enterprise Value 2.37b / FCF TTM 241.8m)
FCF Yield = 10.19% (FCF TTM 241.8m / Enterprise Value 2.37b)
FCF Margin = 73.88% (FCF TTM 241.8m / Revenue TTM 327.3m)
Net Margin = 4.24% (Net Income TTM 13.9m / Revenue TTM 327.3m)
Gross Margin = 66.83% ((Revenue TTM 327.3m - Cost of Revenue TTM 108.6m) / Revenue TTM)
Gross Margin QoQ = 65.72% (prev 67.12%)
Tobins Q-Ratio = 0.70 (Enterprise Value 2.37b / Total Assets 3.38b)
Interest Expense / Debt = 8.00% (Interest Expense 93.7m / Debt 1.17b)
Taxrate = 21.0% (US default 21%)
NOPAT = 69.6m (EBIT 88.1m * (1 - 21.00%))
Current Ratio = 0.05 (Total Current Assets 70.1m / Total Current Liabilities 1.39b)
Debt / Equity = 0.88 (Debt 1.17b / totalStockholderEquity, last quarter 1.33b)
Debt / EBITDA = 5.92 (Net Debt 1.17b / EBITDA 197.0m)
Debt / FCF = 4.82 (Net Debt 1.17b / FCF TTM 241.8m)
Total Stockholder Equity = 1.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.43% (Net Income 13.9m / Total Assets 3.38b)
RoE = 1.04% (Net Income TTM 13.9m / Total Stockholder Equity 1.33b)
RoCE = 2.97% (EBIT 88.1m / Capital Employed (Equity 1.33b + L.T.Debt 1.64b))
RoIC = 2.34% (NOPAT 69.6m / Invested Capital 2.97b)
WACC = 7.25% (E(1.21b)/V(2.38b) * Re(8.15%) + D(1.17b)/V(2.38b) * Rd(8.00%) * (1-Tc(0.21)))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.51%
[DCF Debug] Terminal Value 81.75% ; FCFF base≈196.4m ; Y1≈209.4m ; Y5≈252.1m
Fair Price DCF = 86.22 (EV 5.14b - Net Debt 1.17b = Equity 3.98b / Shares 46.1m; r=7.25% [WACC]; 5y FCF grow 7.40% → 2.90% )
EPS Correlation: -16.80 | EPS CAGR: -30.90% | SUE: -1.41 | # QB: 0
Revenue Correlation: 78.29 | Revenue CAGR: 4.94% | SUE: 0.78 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.09 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.46 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+58.6% | Growth Revenue=+7.2%
P/E Forward = 64.1026
P/S = 3.6073
P/B = 0.7998
Revenue TTM = 327.3m USD
EBIT TTM = 88.1m USD
EBITDA TTM = 197.0m USD
Long Term Debt = 1.64b USD (from longTermDebt, last quarter)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 1.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.17b USD (from netDebt column, last quarter)
Enterprise Value = 2.37b USD (1.21b + Debt 1.17b - CCE 4.36m)
Interest Coverage Ratio = 0.59 (Ebit TTM 88.1m / Interest Expense TTM 148.3m)
EV/FCF = 9.81x (Enterprise Value 2.37b / FCF TTM 241.8m)
FCF Yield = 10.19% (FCF TTM 241.8m / Enterprise Value 2.37b)
FCF Margin = 73.88% (FCF TTM 241.8m / Revenue TTM 327.3m)
Net Margin = 4.24% (Net Income TTM 13.9m / Revenue TTM 327.3m)
Gross Margin = 66.83% ((Revenue TTM 327.3m - Cost of Revenue TTM 108.6m) / Revenue TTM)
Gross Margin QoQ = 65.72% (prev 67.12%)
Tobins Q-Ratio = 0.70 (Enterprise Value 2.37b / Total Assets 3.38b)
Interest Expense / Debt = 8.00% (Interest Expense 93.7m / Debt 1.17b)
Taxrate = 21.0% (US default 21%)
NOPAT = 69.6m (EBIT 88.1m * (1 - 21.00%))
Current Ratio = 0.05 (Total Current Assets 70.1m / Total Current Liabilities 1.39b)
Debt / Equity = 0.88 (Debt 1.17b / totalStockholderEquity, last quarter 1.33b)
Debt / EBITDA = 5.92 (Net Debt 1.17b / EBITDA 197.0m)
Debt / FCF = 4.82 (Net Debt 1.17b / FCF TTM 241.8m)
Total Stockholder Equity = 1.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.43% (Net Income 13.9m / Total Assets 3.38b)
RoE = 1.04% (Net Income TTM 13.9m / Total Stockholder Equity 1.33b)
RoCE = 2.97% (EBIT 88.1m / Capital Employed (Equity 1.33b + L.T.Debt 1.64b))
RoIC = 2.34% (NOPAT 69.6m / Invested Capital 2.97b)
WACC = 7.25% (E(1.21b)/V(2.38b) * Re(8.15%) + D(1.17b)/V(2.38b) * Rd(8.00%) * (1-Tc(0.21)))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.51%
[DCF Debug] Terminal Value 81.75% ; FCFF base≈196.4m ; Y1≈209.4m ; Y5≈252.1m
Fair Price DCF = 86.22 (EV 5.14b - Net Debt 1.17b = Equity 3.98b / Shares 46.1m; r=7.25% [WACC]; 5y FCF grow 7.40% → 2.90% )
EPS Correlation: -16.80 | EPS CAGR: -30.90% | SUE: -1.41 | # QB: 0
Revenue Correlation: 78.29 | Revenue CAGR: 4.94% | SUE: 0.78 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.09 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.46 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+58.6% | Growth Revenue=+7.2%